TrialClinical and vaccine immunology : CVI2011

A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults.

Clayton Harro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.